Contact Us


Your Name (required)

Your Email (required)

Your Phone (required)

Subject

Interested In... (required)

Your Message

WDSrx Participates In DSCSA Panel Discussion At HDA Meeting

The Elephant In The Room: Practical Transitional Strategies To Reach November 27

According to a recent TraceLink survey, 46% of manufacturers are not ‘well-equipped’ to achieve DSCSA compliance prior to the November 28 deadline.  Whether behind the eight-ball or ahead of the curve, this session provides practical solutions to assist with compliance for all industry players at any stage of serialization readiness.  Sharing information to ease the sense of urgency, topics include third party logistics, data collection and transmittal, Track & Trace, compliance assessment and solution implementation.

Brian Daleiden – VP, Industry Marketing; TraceLink

David Colombo –  Director, Management Consulting, Life Sciences; KPMG

Brad Beranek – Senior Manager, Demand Generation; Axway

Matt Finch — Director, Healthcare Solutions Architecture; Axway

Dirk Rodgers — Regulatory Strategist;  SYSTECH

Larry Hotz – Manager, Marketing; WDSrx – Woodfield Distribution, LLC

Session Scheduled Monday, March 6, 2:15 p.m. – 3:15 p.m.

Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.